Albemarle (ALB) Expected to Post Quarterly Earnings on Wednesday

Albemarle (NYSE:ALB) will likely be releasing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Albemarle to post earnings of $3.20 per share and revenue of $1.6069 billion for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB) last posted its quarterly earnings results on Wednesday, May 6th. The specialty chemicals company reported $2.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $1.71. Albemarle had a negative net margin of 5.00% and a positive return on equity of 5.22%. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same quarter last year, the business posted ($0.18) EPS. The firm’s revenue for the quarter was up 32.7% on a year-over-year basis. On average, analysts expect Albemarle to post $13 EPS for the current fiscal year and $12 EPS for the next fiscal year.

Albemarle Stock Up 0.8%

Shares of ALB opened at $118.54 on Tuesday. The firm has a 50 day simple moving average of $141.79 and a two-hundred day simple moving average of $165.35. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.07 and a quick ratio of 1.21. Albemarle has a one year low of $66.67 and a one year high of $221.00. The company has a market cap of $13.98 billion, a P/E ratio of -34.76 and a beta of 1.33.

Albemarle Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, September 11th will be issued a dividend of $0.41 per share. This is an increase from Albemarle’s previous quarterly dividend of $0.41. The ex-dividend date of this dividend is Friday, September 11th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.4%. Albemarle’s payout ratio is presently -47.51%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ALB. Zacks Research downgraded Albemarle from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Weiss Ratings upgraded Albemarle from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Thursday, May 7th. Bank of America boosted their target price on Albemarle from $190.00 to $225.00 and gave the stock a “buy” rating in a research note on Tuesday, April 21st. Oppenheimer raised their price target on shares of Albemarle from $216.00 to $222.00 and gave the company an “outperform” rating in a research note on Monday, April 13th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Albemarle from $210.00 to $250.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Fifteen analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $199.22.

Insider Transactions at Albemarle

In other Albemarle news, CEO J Kent Masters sold 16,393 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $183.72, for a total value of $3,011,721.96. Following the completion of the transaction, the chief executive officer owned 87,519 shares of the company’s stock, valued at $16,078,990.68. This represents a 15.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.42% of the stock is currently owned by insiders.

Institutional Trading of Albemarle

Hedge funds and other institutional investors have recently made changes to their positions in the company. BOKF NA raised its holdings in Albemarle by 5,771.4% in the 3rd quarter. BOKF NA now owns 411 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 404 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in Albemarle by 536.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company’s stock worth $36,000 after acquiring an additional 483 shares during the last quarter. Los Angeles Capital Management LLC acquired a new position in Albemarle in the 4th quarter valued at approximately $65,000. Binnacle Investments Inc increased its position in Albemarle by 260.0% in the 3rd quarter. Binnacle Investments Inc now owns 900 shares of the specialty chemicals company’s stock valued at $73,000 after acquiring an additional 650 shares during the period. Finally, Rakuten Securities Inc. raised its stake in shares of Albemarle by 57.7% during the second quarter. Rakuten Securities Inc. now owns 1,238 shares of the specialty chemicals company’s stock valued at $78,000 after acquiring an additional 453 shares during the last quarter. 92.87% of the stock is currently owned by institutional investors.

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.